Community Regional Cancer Care — Indianapolis, Indiana

Community Regional Cancer Care is a clinical research site located in Indianapolis, Indiana, United States 46219.

Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.

Community Regional Cancer Care has participated in 14 clinical trials with 1 currently active.

Therapeutic areas: Lung Cancer, Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV.

Sponsors: SWOG Cancer Research Network, Radiation Therapy Oncology Group, EMD Serono Research & Development Institute, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Indianapolis

Browse all research sites in Indiana · View every site in Indianapolis

• Community Regional Cancer Care at Community Hospital East
• Indiana University Health University Hospital /ID# 259827
• Riley Child & Adolescent Psychiatry Clinic- Riley Hospital
• Indiana University (IU) School of Medicine
• The Rehabilitation Hospital of Indiana
• Wishard Memorial Hospital
• Indiana University Health, Neurorehabilitation & Robotics
• Indiana University Hospital, Indiana Clinical Research Center, 550 North University Boulevard (Site 840014)
• Indiana University Health Simon Cancer Center
• Indiana University Cancer Center Clinical Research Office
• Indiana University Indiana Univ
• IU Medical Center / Riley Hospital

Sponsor Feasibility Report

Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Community Regional Cancer Care?

Community Regional Cancer Care has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Community Regional Cancer Care conducted?

Community Regional Cancer Care has 14 clinical trials on record, with 1 currently active. Their work covers Lung Cancer, Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV.

Is Community Regional Cancer Care accredited by Crixeo Clinical Trials?

Community Regional Cancer Care has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Community Regional Cancer Care?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.